Quantitative Systems Pharmacology (QSP) & Mechanistic Modeling

Quantitative Systems Pharmacology (QSP) and mechanistic modeling integrate biology, pharmacology, and mathematics to explain how therapeutic agents interact with biological systems. These models capture pathways, cellular behavior, molecular mechanisms, and whole-system dynamics, allowing deeper understanding of drug action, biomaterial interactions, regenerative processes, immune responses, and controlled-release platforms.

Materials Metric supports QSP and mechanistic modeling to help predict therapeutic outcomes, identify key drivers of response, evaluate delivery strategies, optimize dosing, and anticipate variability before preclinical or clinical testing. These approaches guide decision-making for drug delivery systems, biomaterial platforms, implantable devices, and complex biological interfaces.

Core Capabilities

Mechanistic Modeling
• Pathway-based models describing signaling, inflammation, and healing
• ODE/PDE models of molecular, cellular, and tissue dynamics
• Biophysical transport modeling (diffusion, convection, degradation)
• Drug release and absorption modeling for biomaterials and devices
• Simulation of immune activation, fibrosis, remodeling, and integration

Quantitative Systems Pharmacology (QSP)
• Integrated PK/PD + systems biology frameworks
• Exposure–response and mechanism-of-action modeling
• Cytokine, signaling, and immune network modeling
• Virtual populations to capture patient variability
• Scenario testing for dosing, delivery routes, or material design decisions

Material-Integrated QSP Models
• Controlled release from hydrogels, scaffolds, polymers, coatings, and implantable devices
• Modeling of mineralization, osseointegration, cartilage repair, and soft-tissue remodeling
• Inflammation, wound healing, and foreign-body response pathways
• Biofilm inhibition and antimicrobial mechanism modeling
• Integration with histology, imaging, and bio-interface datasets

Applications We Support

• Oncology, immunology, and metabolic diseases
• Regenerative medicine
• Drug-device systems
• Biomaterials and controlled-release systems
• Controlled-release drug delivery and depot platforms
• Tissue engineering and scaffold design
• Dental and orthopedic implant integration
• Wound healing and immune modulation
• Bone, cartilage, and soft-tissue regeneration
• Antimicrobial coatings and biofilm inhibition
• Cell therapy and biologic delivery models

Model Development & Analysis Workflow

• Define mechanisms, pathways, and system boundaries
• Build structured models using ODE/PDE or hybrid approaches
• Estimate parameters using experimental, imaging, or literature-derived data
• Perform sensitivity, uncertainty, and identifiability analysis
• Simulate scenarios for dosing, delivery strategies, and material design
• Provide clear, actionable predictions for R&D or regulatory planning

Why Choose Materials Metric

Materials Metric delivers mechanistic clarity through robust modeling frameworks built by experts in biology, pharmacology, and computational sciences.

We provide:
• High-fidelity QSP models
• ISO 9001:2015 aligned data workflows
• Integration with PK, toxicology, and biomarker data
• Predictive analytics for clinical decision-making

Related services

To learn more about our Quantitative Systems Pharmacology (QSP) & Mechanistic Modeling Service or other testing needs, please contact us.

Frequently Asked Questions

What is quantitative systems pharmacology (QSP) and mechanistic modeling?

Quantitative systems pharmacology (QSP) and mechanistic modeling build mathematical representations of biological pathways, drug targets, and physiological systems to explain and predict drug effects. Materials Metric delivers mechanistic models that link molecular interactions to observed responses and allow simulation of untested conditions. The result is a structured model with assumptions, equations, and interpretation documented for reuse.

What is QSP modeling used for?

QSP modeling is used to explore mechanisms of action, test hypotheses about pathway behavior, predict responses across doses or patient subgroups, and support target and biomarker selection. It can integrate multiple data types into a single quantitative framework and reveal where more experiments would add the most value. This helps prioritize resources before committing to costly studies.

What data and inputs are needed for QSP modeling?

We need information on the biological system of interest, including pathway structure, known interactions, and any kinetic or concentration data available. Published parameters, in vitro measurements, and experimental time-course data all help constrain the model. Where data are sparse, we document assumptions explicitly and run sensitivity analyses to show their impact.

Which methods and tools apply to mechanistic QSP modeling?

We use systems of ordinary differential equations, mass-action and enzyme kinetics, and parameter estimation against available data. Model credibility is assessed through sensitivity analysis, identifiability checks, and comparison to experimental observations. The approach follows accepted mechanistic modeling practice and is tailored to the specific biology rather than a fixed standard.